Aurobindo Pharma
Aurobindo Pharma launches COVID-19 drug Molnupiravir in India
Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions
Aurobindo unit gets 14 observations
Given the sizeable number of observations, it has overshadowed the company’s decent September quarter numbers.
Sebi slaps Rs 22 crore penalty on Aurobindo promoters
The probe found that the promoter entities traded in the scrip with prior price sensitive information.
India to make molecules to cut dependency on China
Recently, the Central government expressed concern about Indian pharma companies’ dependence on China.
Indian drug firms recalling two different drugs
Dr Reddy’s Laboratories and Aurobindo Pharma have separately started recalling two different drugs.
US states blame Aurobindo Pharma for price fixing; shares dip
It sank 4.25 per cent to Rs 665.35 and by noon it was trading at Rs 674.45, down 2.94 per cent.
1 of 1